Our impact
We bring together the brightest minds, boldest ideas and best partners to fast-track scientific breakthroughs for patient benefit. We will ultimately be measured by our impact, and the differences we make for people affected by cancer.
Our purpose is to beat cancer.
We exist to take cutting-edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.
To date, we’ve played an instrumental role in bringing 11 new cancer drugs to market, and forming over 60 startup companies - but that’s not all.
Explore how we're having a real impact on the lives of people affected by cancer.
Our impact in numbers
11
marketed drugs
6m+
we've enabled in excess of 6 million courses of treatment for cancers across the world through drugs that we have directly helped to market
£536m+
revenue from royalties & IP
#2
2nd largest oncology out-licensor globally
150+
active licences
10
major industry alliances in therapeutic innovation
160+
new drugs into early-phase clinical trials
60+
spinouts & startups
£2.3bn+
raised by our spinout and startup portfolio
Success stories
Read the real-life stories from the teams behind some of our key achievements, from bringing drugs to market to spinning out new companies and developing the right partnerships.
